Furthermore, elevated β2-microglobulin levels in the unmutated group indicate a more aggressive disease phenotype, as high β2-microglobulin is correlated with advanced disease stages and poor clinical outcomes in CLL [37]. The gene discussed is HLA-G; the disease is B-cell chronic lymphocytic leukemia.